Compounds > carbocysteine

carbocysteine and Innate Inflammatory Response

carbocysteine has been researched along with Innate Inflammatory Response in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Guan, WJ; Huang, RQ; Wang, W; Xie, YQ; Zheng, JP; Zhong, NS; Zhu, SX1
Macciò, A; Madeddu, C; Mantovani, G; Panzone, F1
Gelfand, EW; Joetham, A; Matsubara, S; Matsuda, H; Miyahara, N; Okamoto, M; Shiraishi, Y; Takeda, K1
Inoue, M; Ishibashi, Y; Nogawa, H; Yasue, T1
Asti, C; Caselli, GF; Clavenna, G; Daffonchio, L; Hernandez, A; Melillo, G; Omini, C1
Ishibashi, Y; Masumoto, Y; Momo, K; Okamura, T; Tachiiri, T1

Reviews

1 review(s) available for carbocysteine and Innate Inflammatory Response

ArticleYear
Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:4

    Topics: Anti-Inflammatory Agents; Antioxidants; Cachexia; Carbocysteine; Humans; Inflammation; Neoplasms; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Treatment Outcome

2009

Other Studies

5 other study(ies) available for carbocysteine and Innate Inflammatory Response

ArticleYear
Carbocisteine attenuates TNF-α-induced inflammation in human alveolar epithelial cells in vitro through suppressing NF-κB and ERK1/2 MAPK signaling pathways.
    Acta pharmacologica Sinica, 2016, Volume: 37, Issue:5

    Topics: A549 Cells; Alveolar Epithelial Cells; Carbocysteine; Cytokines; HEK293 Cells; Humans; Inflammation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Signal Transduction; Tumor Necrosis Factor-alpha

2016
Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation.
    British journal of pharmacology, 2010, Volume: 160, Issue:6

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Carbocysteine; Cyclopropanes; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Eosinophils; Female; Inflammation; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Ovalbumin; Quinolines; Sulfides

2010
Carbocisteine promotes phagocytosis of apoptotic cells by alveolar macrophages.
    European journal of pharmacology, 2012, Feb-29, Volume: 677, Issue:1-3

    Topics: alpha-L-Fucosidase; Animals; Anti-Inflammatory Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Carbocysteine; Cell Count; Female; Fucose; Inflammation; Lipopolysaccharides; Macrophages, Alveolar; Mice; Mice, Inbred BALB C; Neutrophils; Phagocytosis

2012
Effectiveness of carbocysteine lysine salt monohydrate on models of airway inflammation and hyperresponsiveness.
    Pharmacological research, 1995, Volume: 31, Issue:6

    Topics: Acetylcholine; Animals; Carbocysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-1; Lysine; Rats; Respiratory Hypersensitivity; Respiratory System

1995
[Effects of carbocisteine on airway inflammation and related events in SO2-exposed rats].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2001, Volume: 39, Issue:1

    Topics: Ambroxol; Animals; Carbocysteine; Cyclic AMP; Disease Models, Animal; Expectorants; Gases; Inflammation; Male; Rats; Rats, Wistar; Respiratory System; Respiratory Tract Diseases; Sulfur Dioxide

2001